Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Unii-bdt58WJ9WE for Sale > Jinlan 98+ EP/BP/USP Lenacapavir Sodium
Jinlan 98+ EP/BP/USP Lenacapavir Sodium buy - large image1
Jinlan 98+ EP/BP/USP Lenacapavir Sodium buy - image1

Jinlan 98+ EP/BP/USP Lenacapavir Sodium

Unit Price: Get Latest Price
CAS No.:

2283356-12-5

Grade:

medical grade

Content:

98%

Port:

Shanghai/Ningbo/Qingdao

Brand:

Jinlan

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-03-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,API,Intermediate

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    Basic Product Description


    CAS Number: 2283356-12-5

    Chemical Name: Sodium (S)-2-(3-(4-chloro-2-fluorobenzyl)-5-(cyclopropylmethyl)-4,7-dioxo-2,3,4,5,6,7-hexahydro-1H-pyrazolo[4,3-c]pyridin-1-yl)butanoate

    Molecular Formula: C₂₀H₂₁ClFN₃NaO₄

    Molecular Weight: 445.84 g/mol

    Synonyms: GS-6207 sodium, Lenacapavir sodium salt

    Related Categories: Human Immunodeficiency Virus Type 1 (HIV-1) Capsid Inhibitor, Long-Acting Antiretroviral Agent (LA-ARV), Injectable Antiviral API

    Key Highlight: A first-in-class, long-acting HIV-1 capsid inhibitor formulated as a sodium salt; inhibits multiple stages of the HIV-1 viral life cycle including capsid assembly, nuclear entry, and reverse transcription; indicated for the treatment and prevention of HIV-1 infection in adults with long-term subcutaneous administration.

    Basic Info
    Product Name:

    Unii-bdt58WJ9WE

    Other Name:

    UNII-BDT58WJ9WE;BDT58WJ9WE;Lenacapavir sodium;GS-HIV Sodium;GS-HIV Na;Lenacapavir sodium [USAN];GS-6207-02;2283356-12-5

    CAS No.:

    2283356-12-5

    Molecular Formula:

    C39H31ClF10N7NaO5S2

    InChIKeys:

    SSXPGMNGIORJAQ-PZNXWHLTSA-M

    Exact Mass:

    989.1254631

    UNII:

    BDT58WJ9WE

    Categories:

    Other Chemical Drugs

    Characteristics
  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,API,Intermediate

    Location:

    Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1

    Payment Terms:

    100% TT in advance

    Average lead Time:

    275

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2020

    Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd (with its export company Hangzhou Royall Import & Export Co.,Ltd.) is located in Hangzhou, Zhejiang Province. Neighboring Ningbo port, Shanghai port, Hangzhou Xiaoshan Int' l Airport and Shanghai Pudong Int' l Airport, the transportation and production environment are excellent. JINLAN PHARMA mainly business includes: 1) API, Pharmaceutical Intermediates, CMO, CRO, CDMO and so on. 2) Pharmaceutical Equipment such as: Distilled Water Machinery, Mixer, Sterilizer and so on.

    JINLAN PHARM focus on:

    ■ Contrast Agent

    ■ Anti-COVID APIs

    ■ Respiratory System APIs

    ■ Anti-tumor & Anti-Cancer APIs

    ■ Anti-Diabetes APIs

    ■ Anti-HCV & Anti-HBV APIs

    ■ Anti-HIV APIs

    ■ Peptides

    ■ Pharmaceutical Intermediates

    ■ CMO, CRO, CDMO

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.